Brokerages Set Hikma Pharmaceuticals PLC (LON:HIK) PT at GBX 1,972.50
Shares of Hikma Pharmaceuticals PLC (LON:HIK – Get Free Report) have been given a consensus recommendation of “Moderate Buy” by the six research firms that are covering the stock, Marketbeat.com reports. Three analysts have rated the stock with a hold recommendation and three have given a buy recommendation to the company. The average 1-year price […]
More Stories
TeraWulf Sees Unusually High Options Volume (NASDAQ:WULF)
TeraWulf Inc. (NASDAQ:WULF – Get Free Report) was the recipient of unusually large options trading on Wednesday. Stock investors bought...
Microvast Holdings, Inc. (NASDAQ:MVST) Sees Significant Drop in Short Interest
Microvast Holdings, Inc. (NASDAQ:MVST – Get Free Report) was the recipient of a large decrease in short interest in the...
Regions Financial (RF) Scheduled to Post Earnings on Friday
Regions Financial (NYSE:RF – Get Free Report) will be announcing its earnings results before the market opens on Friday, January...
SGS SA (OTCMKTS:SGSOY) Sees Large Increase in Short Interest
SGS SA (OTCMKTS:SGSOY – Get Free Report) was the target of a large growth in short interest in December. As...
ODP (NASDAQ:ODP) Shares Up 6.1% – Still a Buy?
The ODP Co. (NASDAQ:ODP – Get Free Report) traded up 6.1% on Monday . The company traded as high as...
Sandvik AB (publ) (OTCMKTS:SDVKY) Short Interest Update
Sandvik AB (publ) (OTCMKTS:SDVKY – Get Free Report) saw a large increase in short interest in December. As of December...